PON1 is important for the antioxidative mechanism by which HDL opposes atherogenesis, which may provide a better avenue of inquiry in the prevention and treatment of ASCVD [118] than has emerged from the emphasis on its role in RCT. This evidence concerns the gene PON1 and atherosclerosis.